Variability of disease activity in patients treated with ranibizumab for neovascular age-related macular degeneration

被引：0
|
作者：
P Enders
P Scholz
P S Muether
S Fauser
机构：
[1] University Hospital of Cologne,Department of Ophthalmology
来源：
Eye | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1072 / 1076
页数：4
相关论文
共 50 条
  • [41] Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
    Hurley S.F.
    Matthews J.P.
    Guymer R.H.
    Cost Effectiveness and Resource Allocation, 6 (1)
  • [42] Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review
    Takeda, A. L.
    Colquitt, J.
    Clegg, A. J.
    Jones, J.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (09) : 1177 - 1182
  • [43] Assessment of the effectiveness and safety of ranibizumab in neovascular age-related macular degeneration
    Real Campana, Jose Manuel
    Carrera Lafuentes, Patricia
    Torron Fernandez-Blanco, Clemencia
    Huarte Lacunza, Rafael
    Varela Martinez, Isabel
    Rabanaque Hernandez, M. Jose
    MEDICINA CLINICA, 2011, 136 (11): : 471 - 477
  • [44] Pharmacogenetic Studies of Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration
    Den Hollander, A. I.
    Smailhodzic, D.
    Khan, H. A.
    Omar, A.
    Zhang, A. Y.
    Kirchhof, B.
    Chen, J.
    Hoyng, C. B.
    Koenekoop, R. K.
    Fauser, S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [45] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
    Chakravarthy, Usha
    Harding, Simon P.
    Rogers, Chris A.
    Downes, Susan M.
    Lotery, Andrew J.
    Wordsworth, Sarah
    Reeves, Barnaby C.
    OPHTHALMOLOGY, 2012, 119 (07)
  • [46] Ranibizumab port delivery system in neovascular age-related macular degeneration
    Chandrasekaran, Priya R.
    Madanagopalan, V. G.
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2022, 14
  • [47] Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration
    Lai, Timothy Y. Y.
    Chan, Wai-Man
    Liu, David T.
    Lam, Dennis S.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (12) : 1877 - 1880
  • [48] Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration
    Dikmetas, Ozlem
    Kadayifcila, Sibel
    Eldem, Bora
    Feyzullayeva, Ulkar
    NORTHERN CLINICS OF ISTANBUL, 2022, 9 (02) : 173 - 179
  • [49] Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration
    Abouammoh, Marwan
    Sharma, Sanjay
    CURRENT OPINION IN OPHTHALMOLOGY, 2011, 22 (03) : 152 - 158
  • [50] Influence of ranibizumab treatment on the extracellular matrix in patients with neovascular age-related macular degeneration
    Nita, Malgorzata
    Michalska-Malecka, Katarzyna
    Mazurek, Urszula
    Kimsa, Malgorzata
    Strzalka-Mrozik, Barbara
    Grzybowski, Andrzej
    Romaniuk, Dorota
    MEDICAL SCIENCE MONITOR, 2014, 20 : 875 - 883
12345